期刊文献+

宣肺祛瘀通络中药对慢性阻塞性肺疾病急性加重期血气分析及血浆纤维蛋白原的影响 被引量:5

Effect of Xuanfei Quyu Tongluo Chinese herbal medicine on blood gas analysis and plasma fibrinogen of acute exacerbations of chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨宣肺祛瘀通络中药对慢性阻塞性肺疾病(COPD)急性加重期患者血气分析及血浆纤维蛋白原的影响。方法将100例慢性阻塞性肺疾病急性加重期伴有肺动脉高压患者随机分为2组,对照组采取综合治疗方法,治疗组在综合治疗基础上予宣肺祛瘀通络中药治疗。观察2组症状积分;治疗前和治疗后第8d停止吸氧30min后均分别取外周动脉血1mL(肝素抗凝)行血气分析,取静脉血2mL(肝素抗凝)检测血浆纤维蛋白原。结果治疗组治疗后二氧化碳分压[P(CO2)]低于对照组,血氧分压[P(O2)]高于对照组,2组比较差异有统计学意义(P<0.05)。2组治疗后纤维蛋白原水平均较治疗前降低(P<0.05),且2组治疗后比较差异有统计学意义(P<0.05)。治疗组治疗后症状积分与本组治疗前及对照组治疗后比较差异均有统计学意义(P<0.05)。结论宣肺祛瘀通络中药汤剂能够通过降低COPD急性加重期患者血流黏滞度,升高P(O2)水平,降低P(CO2)水平,提高治疗效果。 Objective To explore the effects of Xuanfei Quyu Tangluo decoction on blood gas analysis and plasma fibrinogen in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). Methods 100 cases of acute exacerbation of chronic obstructive pulmonary disease with pulmonary hypertension were randomly divided into 2 groups. Cases in the control group were treated by a comprehensive treatment. Patients in the treatment group were treated by combination of a comprehensive treatment and Xuanfei Quyu Tongluo Chinese medicine. Before treatment, after treatment the first stop on the 8th day 30min oxygen are respectively peripheral arterial 1 mL (heparin) line of blood gas analysis, blood taken 2mL (heparin) measured fibrinogen. Result The effective rate in the control group was lower than that in the treatment group. The partial pressure of carbon dioxide [ P( CO2 ) ] and plasma fibrinogen levels in the treatment group was lower than that in the control group, blood oxygen partial pressure [ P(O2 ) ] in treatment group wan higher than that in control group. There were significant differences between two groups ( P 〈 0.05). Conclusion Xuanfei Quyu Tongluo decoction can improve effect of acute exacerbation of COPD patients by decreasing blood viscosity and the level of P( CO2 ), and increasing the level of P(O2 ).
出处 《河北中医》 2009年第1期8-10,共3页 Hebei Journal of Traditional Chinese Medicine
基金 河北省中医药管理局科学研究计划项目(编号:2007160)
关键词 中药疗法 肺疾病 阻塞性 急性病 慢性病 血气监测 经皮 纤维蛋白原 Xuanfei Quyu Tongluo Chinese herbal medicine Chronic obstructive pulmonary disease with acute ex-acerbation Blood oxygen partial pressure Carbon dioxide partial pressure Plasma fibrinogen
  • 相关文献

参考文献6

二级参考文献36

  • 1申红恩,申利静,张海柱.慢性肺源性心脏病合并心力衰竭血清、痰中白细胞介素及C反应蛋白的临床意义[J].实用诊断与治疗杂志,2004,18(5):367-368. 被引量:6
  • 2于化鹏,刘兰平,王钧,古国贤.肺心病患者血小板膜蛋白P-selectin与血小板功能的变化[J].中华内科杂志,1995,34(1):13-15. 被引量:19
  • 3游德江.血府逐瘀胶囊治疗肺心病急性发作32例疗效观察[J].北京中医,2002,19:49-50.
  • 4叶任高 陆再英.内科学[M].北京:人民卫生出版社,2002.216.
  • 5Ashitani J, Mukae H, Arimura Y, et al. Elevated plasmap rocoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease[J]. Intern Med, 2002,41 (3)181.
  • 6CooK N S, Ubben D. Fibrinogcn as a major risk in cardiovascular disease [J]. Trends Pharmacol Sci, 1990,11 (4) : 444.
  • 7Ernst E. Fibrinogen: an important risk factor for atherothrombotic diseases [J]. Ann Med, 1994, 26 (1) : 15.
  • 8Danl M, Tybjaerg Hansen A, Vestbo J, et al. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001, 15,164(6):1008.
  • 9Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation[J]. N Engl J Med, 1999,340(4):448.
  • 10Cordova C, Violi F, Alessandri C, et al. Improvement of blood gas levels after calciumheparin treatment in patients with chronic obstructive pulmonary disease [J]. Thromb Res, 1992,68 (3)435.

共引文献5257

同被引文献57

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部